What you should know about RSV

You are probably reading a lot about a surge of cases of respiratory viruses like respiratory syncytial virus (RSV), influenza (the flu) and SARS-CoV-2, which causes COVID-19. The triple threat of...
Read More
Protecting against influenza: A conversation with David Ross, Vice President, Commercial Operations, North America, CSL Seqirus

Our industry is at the forefront of fighting the annual influenza virus. I recently had the chance to connect with David Ross, Vice President, Commercial Operations, North America, CSL Seqirus about...
Read More
New report shows more than 400 medicines and vaccines in development to tackle infectious diseases, including COVID-19

Throughout history, infectious diseases caused by pathogens such as bacteria or viruses have taken a devastating toll on the lives and security of people around the world. With the ongoing COVID-19...
Read More
New report shows nearly 260 vaccines in development, including dozens for COVID-19

Vaccines represent some of the most impactful advances in public health, helping to prevent the spread of many infectious diseases and, in many parts of the world, eliminating some of the most...
Read More
Merck’s Dr. Julie Gerberding on the threat of antimicrobial resistance and COVID-19

As America’s biopharmaceutical companies work around the clock to combat COVID-19, a disease caused by a novel strain of coronavirus, now is an important time to consider how we can prepare for the...
Read More
The biopharmaceutical industry’s unique role in responding to COVID-19

As the outbreak of COVID-19, a disease caused by a novel strain of coronavirus, evolves in the United States and around the globe, both the private and public sectors are working around the clock to...
Read More
COVID-19 Response: Supporting the frontline

Updated 7/13/2020 In these unprecedented times, America’s biopharmaceutical companies are coming together to achieve one shared goal: to combat COVID-19, a disease caused by a novel strain of...
Read More
Guest post: Looking out for the invisibly vulnerable in the time of COVID-19

Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...
Read More
America’s biopharmaceutical companies are working around the clock to beat coronavirus

Today, the Pharmaceutical Research and Manufacturers of America (PhRMA) and the Biotechnology Innovation Organization (BIO) underscored the industry’s commitment to finding solutions to prevent,...
Read More
Guest post: Takeda’s efforts to address COVID-19

Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest ...
Read More